Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol + vasopressin versus vasopressin alone for bleeding reduction during minimally invasive myomectomy
IRCT2015062222871N1Phase 2Completed
- Sponsor
- Vice chancellor for research,Shiraz University of Medical Sciences
- Start
- Mar 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Fibromyoma (LM) comparing Misoprostol + vasopressin with Vasopressin alone (2 arms). Started Mar 2016; status: completed.
02
Drugs
misoprostolvasopressin
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT2015062222871N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015062222871N1.